<!-- benC.html -->
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Dr. Ben Chin-Yee</title>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
  <header>
    <nav>
      <a href="index.html">About</a>
      <a href="team.html">Team</a>
      <a href="publications.html">Publications</a>
      <a href="news.html">News</a>
      <a href="contact.html">Contact</a>
    </nav>
  </header>

  <main>
    <section class="profile-page">
      <h2>Dr. Ben Chin-Yee</h2>
      <img src="images/BenProfilePic.jpg" alt="Dr. Ben Chin-Yee" class="profile-pic" />
      <p><strong>Role:</strong> Dr. Benjamin Chin-Yee is Division Head of Hematology at London Health Sciences Centre and Assistant Professor in Pathology and Laboratory Medicine at the Schulich School of Medicine & Dentistry, Western University, with cross-appointments in Hematology (Department of Medicine) and Philosophy. He is also an Associate Scientist at the London Health Sciences Centre Research Institute.</p>
      
      <h2>Education</h2>
      <p>MD and MA from University of Toronto. PhD candidate and Gates Scholar in History and Philosophy of Science at the University of Cambridge. </p>

      <h2>Research Interests</h2>
      <ul>
        <li>Dr. Chin-Yee’s research sits at the intersection of clinical hematology, philosophy of medicine, and health technology. His interests include molecular hematology (especially erythrocytosis, myeloid neoplasms, and thrombocytosis), clinical decision-making, shared decision-making in hematology, artificial intelligence and digital health in oncology, and the epistemology of biomarkers and precision medicine.</li>
        <li>Dr. Chin-Yee is currently accepting students/trainees interested in research projects in hematology, philosophy, medical communication, and bioethics.</li>
      </ul>

      <h2>Current Projects</h2>
      <ul>
        <li>He is leading projects on diagnostic approaches to erythrocytosis and thrombocytosis, the role of SH2B3 mutations and TP53 alterations in hematologic disease, and quality improvement initiatives in genomic diagnostics. His philosophical research explores the ethical and epistemological dimensions of AI and big data in medicine, precision oncology, and shared decision-making. Dr. Chin-Yee also contributes to international collaborations, including the International Hemoglobinopathy Research Network (INHERENT), and is actively engaged in research on equity and trust in medical AI.</li>
      </ul>
    </section>
  </main>

  <footer>
    <p>© 2025 Our Research Lab</p>
  </footer>
</body>
</html>
